Pfizer yet to decide on Pain Therapeutics' painkiller

(Reuters) - Pain Therapeutics Inc said Pfizer Inc, its marketing partner for painkiller Remoxy, was yet to decide on continuing to seek regulatory approval for the drug. Shares of Pain Therapeutics fell 20 percent in light trading before the bell. Shares of Durect Corp, which provided the technology used in Remoxy, fell about 13 percent. Pfizer said it appeared there was a "regulatory pathway forward" for the drug, which it discussed with the U.S. Food and Drug Administration in a meeting on March 28. ... via Health News Headlines - Yahoo! News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/05/pfizer-yet-to-decide-on-pain.html